emapticap pegol (NOX E36) - Noxxon
Bio 2012 (Noxxon) - Jul 5, 2012 - Anticipated interim data for P2a trial for diabetic nephropathy in Q4 2012; Anticipated final data for P2a trial for diabetic nephropathy in mid-2013; Anticipated POC data for P2a trial for diabetic nephropathy in 2012 
Anticipated P2a data Diabetes
http://www.larvolonline.com/tlg/ccdb/NoxxonPharmaBio2012Jun212012.pdf
 
Jul 5, 2012
 
NOX-E36 --- Phase IIa started: Interim data expected 4Q-2012, final report anticipated mid-2013 Anticipated POC data for P2a trial for diabetic nephropathy in 2012 ---